BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10745504)

  • 1. Treatment of unstable angina: the role of platelet inhibitors and anticoagulants.
    Cohen M
    J Invasive Cardiol; 1999 Mar; 11(3):147-59. PubMed ID: 10745504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Bhatt DL; Topol EJ
    JAMA; 2000 Sep; 284(12):1549-58. PubMed ID: 11000650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.
    Tcheng JE
    Am Heart J; 1999 Oct; 138(4 Pt 2):261-2. PubMed ID: 10502231
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycoprotein IIb/IIIa antagonists and low-molecular weight heparin in acute coronary syndromes.
    Vernon SM
    Cardiol Clin; 2001 May; 19(2):235-52, vi. PubMed ID: 11407108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
    Berkowitz SD
    Haemostasis; 2000; 30 Suppl 3():27-43. PubMed ID: 11182626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of acute coronary syndrome with glycoprotein IIb/IIIa antagonists].
    Araujo R; Agustí A
    Med Clin (Barc); 2000 Oct; 115(11):435-7. PubMed ID: 11093849
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Roe MT; Sapp SK; Lincoff AM
    Cleve Clin J Med; 2000 Feb; 67(2):131-40. PubMed ID: 10680279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy.
    Juran NB
    Am Heart J; 1999 Oct; 138(4 Pt 2):297-306. PubMed ID: 10502235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR
    Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule glycoprotein IIb/IIIa receptor inhibitors as upstream therapy in acute coronary syndromes: insights from the TACTICS TIMI-18 trial.
    Cannon CP
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):43S-48S. PubMed ID: 12644340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.
    Chew DP; Moliterno DJ
    Cleve Clin J Med; 2001 Dec; 68(12):1017-23. PubMed ID: 11765119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina.
    Steinhubl SR; Moliterno DJ
    Heart Vessels; 1997; Suppl 12():148-55. PubMed ID: 9476567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycoprotein IIb/IIIa inhibitors in unstable angina].
    Boughalem K; Pagny JY; Demichéli T; Danchin N
    Ann Cardiol Angeiol (Paris); 2001; 50(7-8):377-84. PubMed ID: 12555630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing the battle against acute ischemic syndromes: a focus on the GP IIb-IIIa inhibitors.
    Dobesh PP; Latham KA
    Pharmacotherapy; 1998; 18(4):663-85. PubMed ID: 9692642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML
    Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract]   [Full Text] [Related]  

  • 17. Redefining medical treatment in the management of unstable angina.
    Braunwald E; Califf RM; Cannon CP; Fox KA; Fuster V; Gibler WB; Harrington RA; King SB; Kleiman NS; Theroux P; Topol EJ; Van de Werf F; White HD; Willerson JT
    Am J Med; 2000 Jan; 108(1):41-53. PubMed ID: 11059440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes.
    Harrington RA
    Am Heart J; 1999 Oct; 138(4 Pt 2):276-86. PubMed ID: 10502233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current issues with glycoprotein IIb-IIIa antagonists.
    Schneider DJ
    Curr Drug Targets; 2011 Nov; 12(12):1813-20. PubMed ID: 21718238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization.
    Dangas G; Colombo A
    Am Heart J; 1999 Jul; 138(1 Pt 2):S16-23. PubMed ID: 10385787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.